Alan C. Mendelson
General Counsel & Secretary at Optivia Biotechnology, Inc.
Alan C. Mendelson
Alan C. Mendelson
General Counsel & Secretary at Optivia Biotechnology, Inc.


Learn how non-profit organizations benefit from RelSci




Alan C. Mendelson is affiliated with Cadence Design Systems, Inc., Latham & Watkins LLP, EarlyBird LLC, Renovis, Inc., Amgen, Inc., Heron Therapeutics, Inc., Agensys, Inc., Bayhill Therapeutics, Inc., Omniox, Inc., RiboGene, Inc., CoCensys, Inc., Cooley LLP, LEAD Therapeutics, Inc., Complete Genomics, Inc., Coherus BioSciences, Inc., Principia Biopharma, Inc., Paratek Pharmaceuticals Inc., Ardelyx, Inc., InteKrin Therapeutics, Inc., Limerick BioPharma, Inc., iontherapeutics, Inc., Corvus Pharmaceuticals, Inc., Cardiogen Sciences, Inc., Mellanox Technologies Ltd., Optivia Biotechnology, Inc., Singulex, Inc., Coherus BioSciences, Inc., LEAD Therapeutics, Inc., MedImmune Vaccines, Inc., iScribe, Inc., Amicrobe, Inc., Valentis, Inc., QLT, Inc., Novelion Therapeutics, Inc., Ionis Pharmaceuticals, Inc., OncoMed Pharmaceuticals, Inc., Receptor BioLogix, Inc., Axys Pharmaceuticals, Inc., US Search.com, Inc., Complete Genomics, Inc., University of California Berkeley Foundation, California Life Sciences Association, University of California - Berkeley, American Friends of Rambam Medical Center, University of California, Berkeley - College of Chemistry, California Healthcare Institute, The Scripps Research Institute - California, University of California, Biotechnology Innovation Organization, National Kidney Foundation of Northern California, Harvard University - Harvard Law School, The Bay Area Bioscience Association, California Alumni Association